Complete Up To Date Information about Protazil™.
NADA Number: 141-268 | |
| Proprietary Name |
Protazil™ |
|---|---|
| Sponsor |
Schering-Plough Animal Health Corp. |
| Sponsor Address |
P.O. Box 21 Sandown Village, NJ 3171 VIC Australia |
| Ingredients |
Diclazuril |
| Species |
Horse, no use class stated or implied |
| Routes of Administration |
Per Os |
| Dose Form |
Pellet |
| Drug Form |
Pellet |
| Dispensing Status |
RX |
| Patent Number |
4631278 5830893 5883095 |
| Exclusivity |
New approval (dose form) |
|
Dosage Amount, Indications & Limitations |
520.606 Diclazuril Specifications Each 100 grams of pellets contain 1.56 grams diclazuril. Horses Amount Administer 1 milligram per kilogram (0.45 milligrams per pound) of body weight in the daily grain ration for 28 days. Indications For the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. Limitations Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |
| Tolerances |
Chickens: Liver. Tolerances are established for residues of parent diclazuril (the marker residue) is 3 parts per million Muscle. The tolerance for parent diclazulril (the marker residue) is 0.5 parts per million. Skin/fat. The tolerance for parent diclazuril (the marker residue) is 1 part per million. Turkeys: Liver. Tolerances are established for residues of parent diclazuril (the marker residue) is 3 parts per million Muscle. The tolerance for parent diclazulril (the marker residue) is 0.5 parts per million. Skin/fat. The tolerance for parent diclazuril (the marker residue) is 1 part per million. |